DOI: 10.1055/s-00000069

Seminars in Liver Disease

LinksClose Window

References

Huang WC, Hsieh YL, Hung CM. et al.
BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib.

PLoS One 2013;
8 (12) e83627

Download Bibliographical Data

Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.